we are

Our Team

people are our greatest asset

We’re a next-generation liquid biopsy company.

Our mission is to enable a world where cancer can be detected early, diagnosed accurately, managed precisely, and ultimately cured.


Babak Alipanahi
Founder & Chief Scientific Officer
Patrick Arensdorf
Founder & Chief Executive Officer
Seema Singh Bhan
Senior Advisor, Public Policy and External Affairs
Kimberly Chau
VP of Clinical Operations
Cheryl Chin
VP of Marketing
Lisa Fish
Senior Director of Research
Anna Hartwig
VP of Product and Technology Development
Fereydoun Hormozdiari
Senior Director of Computational Biology & Algorithms
Lisa Grismer
Head of Project & Portfolio Management
Nelson Lee
Chief Administrative Officer
Helen Li
Senior Director of Software & Data Engineering
Michael Multhaup
Senior Staff Scientist in Computational Biology
Raaj Trivedi
VP of Corporate Development
Carolyn Wang
Head of People and Culture
Emi Zychlinsky
Executive Vice President of Operations


Founder & Scientific Advisor
Clinical Advisor
Scientific Advisor
Business Advisor
Section 32


Board Director
Casdin Capital
Board Director
Section 32
Board Observer
Two Sigma Ventures
Board Observer
Blue Venture Fund


  • Section 32's logo
  • Casdin Capital's logo
  • Two Sigma Ventures' logo
  • Blue Venture Fund's logo
  • Moore Strategic Ventures' logo

Our History

to build a new venture from the ground up...

it really takes a village.

Dr. Hani Goodarzi, Founder & Scientific Advisor
Hani in his lab at UCSF
Credit: Mario Sanchez, UCSF

Our Story

in the beginning

The oncRNA technology began in the laboratories of the University of California, San Francisco.

Dr. Hani Goodarzi and Dr. Lisa Fish discovered the potential of identifying cancer-specific oncRNAs. By looking where others in the field had not, they discovered new biomarkers that will pave the way to changing the future of diagnostics.

Read the Publication >
Amy giving a presentation

Right Now

RNA offers hope

Now, we are the veterans in the field.

Exai brings together intrepid leaders in the fields of RNA biology, liquid biopsy, and artificial intelligence who are joining forces to fulfill our vision.

Academics & Industry Experience

  • UCSF, Stanford University, MIT, Karolinska Institute, University of Waterloo, Rockefeller University, Princeton University, Johns Hopkins University, UCLA, UC Berkeley, and many more
  • Bluestar Genomics, Illumina, Guardant Health, Myriad Genetics, Google, 23andMe, Deep Genomics, Exact Sciences
Join Our Team>
One of our scientists working under the fume hood

Looking Ahead

changing the future of cancer

The vision and the means to act on it.

We plan to change the future of early cancer detection by providing clinical insights into cancer biology. And that future looks a lot brighter.

It requires a lot of hard work, dedication, and collaboration. If that sounds exciting to you, check out our current open jobs.


Want to get to know us better?
Send us a message.

contact us
Close the cookie popup
Cookie Settings
By clicking "Accept All", you are agreeing to store cookies on your device to enhance your experience and help Exai's marketing.
Accept All
cookie settings